11-82850041-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005040.4(PRCP):āc.624G>Cā(p.Gln208His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000702 in 1,452,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00038 ( 0 hom., cov: 32)
Exomes š: 0.000035 ( 0 hom. )
Consequence
PRCP
NM_005040.4 missense
NM_005040.4 missense
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 0.397
Genes affected
PRCP (HGNC:9344): (prolylcarboxypeptidase) This gene encodes a member of the peptidase S28 family of serine exopeptidases. The encoded preproprotein is proteolytically processed to generate the mature lysosomal prolylcarboxypeptidase. This enzyme cleaves C-terminal amino acids linked to proline in peptides such as angiotension II, III and des-Arg9-bradykinin. The cleavage occurs at acidic pH, but the enzyme activity is retained with some substrates at neutral pH. This enzyme has been shown to be an activator of the cell matrix-associated prekallikrein. The importance of angiotension II, one of the substrates of this enzyme, in regulating blood pressure and electrolyte balance suggests that this gene may be related to essential hypertension. A pseudogene of this gene has been identified on chromosome 2. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06476775).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRCP | NM_005040.4 | c.624G>C | p.Gln208His | missense_variant | 5/9 | ENST00000313010.8 | NP_005031.1 | |
PRCP | NM_199418.4 | c.687G>C | p.Gln229His | missense_variant | 6/10 | NP_955450.2 | ||
PRCP | NM_001319214.2 | c.309G>C | p.Gln103His | missense_variant | 4/8 | NP_001306143.1 | ||
PRCP | XM_005274093.2 | c.309G>C | p.Gln103His | missense_variant | 5/9 | XP_005274150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRCP | ENST00000313010.8 | c.624G>C | p.Gln208His | missense_variant | 5/9 | 1 | NM_005040.4 | ENSP00000317362 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000376 AC: 57AN: 151612Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
57
AN:
151612
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000106 AC: 20AN: 187930Hom.: 0 AF XY: 0.0000969 AC XY: 10AN XY: 103178
GnomAD3 exomes
AF:
AC:
20
AN:
187930
Hom.:
AF XY:
AC XY:
10
AN XY:
103178
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000346 AC: 45AN: 1300396Hom.: 0 Cov.: 30 AF XY: 0.0000327 AC XY: 21AN XY: 641364
GnomAD4 exome
AF:
AC:
45
AN:
1300396
Hom.:
Cov.:
30
AF XY:
AC XY:
21
AN XY:
641364
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000376 AC: 57AN: 151726Hom.: 0 Cov.: 32 AF XY: 0.000445 AC XY: 33AN XY: 74150
GnomAD4 genome
AF:
AC:
57
AN:
151726
Hom.:
Cov.:
32
AF XY:
AC XY:
33
AN XY:
74150
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
15
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2023 | The c.687G>C (p.Q229H) alteration is located in exon 6 (coding exon 6) of the PRCP gene. This alteration results from a G to C substitution at nucleotide position 687, causing the glutamine (Q) at amino acid position 229 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
D;D;T;T;T;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;.;.;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Benign
D;D;T;T;T;T;T
Sift4G
Uncertain
D;D;.;.;.;.;.
Polyphen
B;.;.;.;.;.;.
Vest4
MutPred
Loss of catalytic residue at Q208 (P = 0.0278);.;.;.;.;.;.;
MVP
MPC
0.048
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at